The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man.
D000328:Adult; D000731:Androstanes / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D004576:Electromyography; D005260:Female; D006801:Humans; D008875:Middle Aged; D009132:Muscles; D009388:Neostigmine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects*; D010880:Piperidines / Q000494:pharmacology*; D011674:Pulse / Q000187:drug effects; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D013746:Tetany / Q000139:chemically induced; D014403:Tubocurarine / Q000494:pharmacology*
D000731:Androstanes; D010880:Piperidines; D000644:Quaternary Ammonium Compounds; D009388:Neostigmine; D014403:Tubocurarine